Drugmaker Pfizer Inc. has signed a deal with a UN-backed group to allow other manufacturers to make its experimental Covid-19 pill, a move that could make the treatment available to more than half of the world’s population.

The Directorate General of Drug Administration (DGDA) has issued emergency use authorisation (EUA) to the Pfizer mRNA Covid-19 vaccine in the country today.